-
Item confirms peer-reviewed
Modelled measles scale-up in Kenya averts 879 deaths over ten years
A Markov model of measles vaccination in Kenya estimated that maintaining current funding would avert 213 deaths over ten years at $1,269 per DALY averted, while reaching 95% two-dose coverage would avert 879 deaths at $1,093 per DALY averted, at a very high cost to the health budget.
-
Item new preprint
Daraxonrasib is estimated at $500,637 per QALY in pancreatic cancer at US launch price
A modelled economic evaluation of daraxonrasib in previously treated metastatic pancreatic adenocarcinoma estimated 0.506 additional QALYs at an incremental cost of $253,171, or $500,637 per QALY at the $39,800 monthly launch price, in a preprint not yet peer reviewed.
